A detailed history of American Portfolios Advisors transactions in Medpace Holdings, Inc. stock. As of the latest transaction made, American Portfolios Advisors holds 532 shares of MEDP stock, worth $193,424. This represents 0.0% of its overall portfolio holdings.

Number of Shares
532
Holding current value
$193,424
% of portfolio
0.0%

Shares

13 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2022

Mar 17, 2023

BUY
$145.13 - $182.49 $77,209 - $97,084
532 New
532 $83.6 Million
Q2 2022

Mar 20, 2023

BUY
$130.2 - $168.03 $8,983 - $11,594
69 Added 12.97%
601 $90 Million
Q1 2022

Mar 21, 2023

BUY
$138.87 - $214.31 $9,026 - $13,930
65 Added 12.22%
597 $97.7 Million
Q4 2021

Mar 21, 2023

BUY
$182.74 - $227.9 $4,568 - $5,697
25 Added 4.7%
557 $121 Million
Q3 2021

Mar 22, 2023

SELL
$170.18 - $198.21 $32,674 - $38,056
-192 Reduced 36.09%
340 $64.4 Million
Q2 2021

Mar 22, 2023

SELL
$158.62 - $194.3 $36,482 - $44,689
-230 Reduced 43.23%
302 $53.3 Million
Q1 2021

Mar 22, 2023

SELL
$132.02 - $168.26 $44,622 - $56,871
-338 Reduced 63.53%
194 $31.8 Million
Q4 2020

Mar 22, 2023

SELL
$109.38 - $149.19 $48,236 - $65,792
-441 Reduced 82.89%
91 $12.7 Million
Q3 2020

Mar 22, 2023

SELL
$92.95 - $130.61 $41,362 - $58,121
-445 Reduced 83.65%
87 $9.72 Million
Q2 2020

Mar 24, 2023

BUY
$68.08 - $95.68 $1,497 - $2,104
22 Added 25.0%
110 $10.2 Million
Q1 2020

Mar 24, 2023

SELL
$61.71 - $101.95 $27,399 - $45,265
-444 Reduced 83.46%
88 $6.46 Million
Q4 2019

Mar 24, 2023

SELL
$70.08 - $84.64 $31,956 - $38,595
-456 Reduced 85.71%
76 $6.39 Million
Q3 2019

Mar 24, 2023

SELL
$62.38 - $85.89 $28,445 - $39,165
-456 Reduced 85.71%
76 $6.39 Million

Others Institutions Holding MEDP

About Medpace Holdings, Inc.


  • Ticker MEDP
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Diagnostics & Research
  • Shares Outstandng 31,099,900
  • Market Cap $11.3B
  • Description
  • Medpace Holdings, Inc. provides clinical research-based drug and medical device development services in North America, Europe, and Asia. It offers a suite of services supporting the clinical development process from Phase I to Phase IV in various therapeutic areas. The company also provides clinical development services to the pharmaceutical, bi...
More about MEDP
Track This Portfolio

Track American Portfolios Advisors Portfolio

Follow American Portfolios Advisors and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of American Portfolios Advisors, based on Form 13F filings with the SEC.

News

Stay updated on American Portfolios Advisors with notifications on news.